Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

The Company joins innovation and growth leaders on Nasdaq Company's U.S. Ticker symbol to remain "CGC" SMITHS FALLS, ON, Nov. 3, 2020 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) announced today it will be transferring its U.S. stock...

Canopy Growth to Move U.S. Stock Exchange Listing to Nasdaq

Many stocks are showing a bit of anxiety in front of Election Day, but investors have already cast their vote in favor of buying CGC stock. The post No, It's Not Too Late to Buy Canopy Growth Stock appeared first on InvestorPlace.

No, It's Not Too Late to Buy Canopy Growth Stock

Curaleaf Holdings, Inc.

These pot stocks flew higher last month. Can their sizzling momentum continue?

3 Best Marijuana Stocks of October: Are They Buys Now?

Apple

Zoom Video

Clorox

Zoom Video, Apple, Clorox and Canopy Growth were our top stock trades for Tuesday. That said, let's look at the charts now.

4 Top Stock Trades for Tuesday: ZM, CLX, AAPL, CGC

Aurora Cannabis

Aphria

Cronos Group

Innovative Industrial Properties

Scotts Miracle-Gro

Trulieve Cannabis Corp.

Tilray Brands

Find out what sent cannabis companies through the roof.

Stock Markets Bounced Monday, but These Pot Stocks Really Smoked Higher

Altria

Decriminalizing pot won't solve all these problems.

5 Ways the Federal Government Is Harming the Cannabis Industry

SMITHS FALLS, ON, Nov. 2, 2020 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results for the second quarter fiscal 2021 ended September 30, 2020 before financial markets open on November 9, 2020. Following...

Canopy Growth to Report Second Quarter Fiscal 2021 Financial Results on November 9, 2020

Green Thumb Industries Inc.

A huge spike in sales in a number of U.S. states could push the federal government closer to legalizing pot.

Could COVID-19 Catalyze Marijuana Legalization in the U.S.?

American Airlines

Eastman Kodak

Uber

Popular companies don't always make for profitable stocks.

4 Brand-Name Stocks to Avoid Like the Plague

Canopy Growth has been volatile, but CGC stock is the best of the bunch when it comes to this industry. Let's take a closer look.

Canopy Growth Stock Should Be Back On Your Radar

With pharmaceuticals struggling to find a solution for Covid-19, could cannabis as a therapeutic candidate bolster CGC stock? The post Here's How the Coronavirus Could Benefit Canopy Growth appeared first on InvestorPlace.

Here's How the Coronavirus Could Benefit Canopy Growth

Constellation Brands

The U.S. election could be a bullish catalyst for marijuana stocks. However, a "blue wave" would be better for certain stocks than others.

Ranking the ‘Big 4' Canadian Marijuana Stocks From Best to Worst

Last week's Election 2020 debate was a disappointment -- for cannabis fans.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Were Down 5% (and More) on Monday

Amplify Alternative Harvest ETF

Conditions for the marijuana industry are on an upswing. For CGC stock to ride the wave, Canopy needs to focus on profitability.

Canopy Is at a Crossroads in the Changing Marijuana Market

Amazon

These stocks can add long-term wealth to your portfolio.

The Top 3 Best Stocks to Buy Now

Legalizing marijuana is often cited as a way to mitigate fiscal deficits for states and countries.

Can Legal Cannabis Relieve Fiscal Deficits? These Economists Say 'Not Necessarily'

Canadians are smoking 'em if they got 'em.

Why Marijuana Stocks Canopy Growth, Tilray, and Aurora Cannabis All Rose on Wednesday

It's nothing but the volatility that's typical for Canadian pot stocks.

Why Marijuana Stocks Aurora Cannabis, Canopy Growth, and Tilray Are Giving Up Much of Monday's Gains

Within a month, marijuana could be mostly legal in 3 out of 4 U.S. states.

Why Marijuana Stocks Are Rocking Monday

This Canadian marijuana company provides lucrative opportunities for long-term investing.

The Best Pot Stock for the Next 10 Years

Investors are starting to turn bullish on the cannabis industry again.

Why Are Pot Stocks Popping?

Which stock wins in a matchup between two of the biggest cannabis companies in North America?

Better Marijuana Stock: Curaleaf vs. Canopy Growth

Ceridian HCM Holding Inc.

FirstService

Thomson Reuters

The Toronto Stock Exchange 300 Composite Index is down 3.2% year to date through Oct. 13. Here are 10 Canadian stocks to buy for the rebound.

10 Canadian Stocks to Buy for the Recovery in 2021 and Beyond

HEXO Corp

OrganiGram Holdings Inc.

When Will Canadian Marijuana Stocks Be Profitable?

With new states set to legalize cannabis this November, and the possibility of federal legalization looming, will the marijuana stocks finally live up to the hype?

Is it Finally Time to Buy Marijuana Stocks?

News for Canopy Growth Stock (CGC)